Christian Angermayer - 05 Jan 2024 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
Director, 10%+ Owner
Signature
/s/ Ryan Barrett, Attorney-in-fact
Issuer symbol
ATAI
Transactions as of
05 Jan 2024
Net transactions value
$0
Form type
4
Filing time
09 Jan 2024, 17:00:13 UTC
Previous filing
25 May 2023
Next filing
14 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATAI Stock Option Award $0 +642,000 $0.000000 642,000 05 Jan 2024 Common Shares 642,000 $1.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest with respect to 25% of the shares on January 5, 2025, and will vest with respect to the remaining shares in 36 monthly installments thereafter.